(Q33785134)

29 July 2017

1 reference

title

Activation of erythropoietin signaling by receptor dimerization (English)

1 reference

29 July 2017

1 reference

S S Watowich

1

1 reference

29 July 2017

1 October 1999

1 reference

International Journal of Biochemistry & Cell Biology

29 July 2017

1 reference

29 July 2017

31

1 reference

29 July 2017

1075-1088

1 reference

29 July 2017

10

1 reference

Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Role of the kidney in erythropoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Treatment of the anemia of progressive renal failure with recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Recombinant human erythropoietin for patients with AIDS treated with zidovudine

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Structural design and molecular evolution of a cytokine receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

A new cytokine receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Cytokine receptor signalling

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Homodimerization and constitutive activation of the erythropoietin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Activation and inhibition of erythropoietin receptor function: role of receptor dimerization

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

A dominant negative erythropoietin (EPO) receptor inhibits EPO-dependent growth and blocks F-gp55-dependent transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interaction.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Efficiency of signalling through cytokine receptors depends critically on receptor orientation

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Expression cloning of the murine erythropoietin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Friend spleen focus-forming virus glycoprotein gp55 interacts with the erythropoietin receptor in the endoplasmic reticulum and affects receptor metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Increased cell surface expression and enhanced folding in the endoplasmic reticulum of a mutant erythropoietin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Identification of a cytoplasmic motif in the erythropoietin receptor required for receptor internalization

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Dileucine-based sorting signals bind to the beta chain of AP-1 at a site distinct and regulated differently from the tyrosine-based motif-binding site

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Murine erythroleukaemia cells (Friend cells) possess high-affinity binding sites for erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

An activating mutation in the murine erythropoietin receptor induces erythroleukemia in mice: A cytokine receptor superfamily oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Expression of a constitutively active erythropoietin receptor in primary hematopoietic progenitors abrogates erythropoietin dependence and enhances erythroid colony-forming unit, erythroid burst-forming unit, and granulocyte/macrophage progenitor gr

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

A constitutively activated erythropoietin receptor stimulates proliferation and contributes to transformation of multipotent, committed nonerythroid and erythroid progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Absence of cytokine receptor-dependent specificity in red blood cell differentiation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Activation of the erythropoietin (EPO) receptor by bivalent anti-EPO receptor antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Ligand-induced activation of chimeric receptors between the erythropoietin receptor and receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

A proliferation switch for genetically modified cells

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Human growth hormone and extracellular domain of its receptor: crystal structure of the complex

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

A hot spot of binding energy in a hormone-receptor interface

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

The role of receptor dimerization domain residues in growth hormone signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Dimerization of cell surface receptors in signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Cytokine receptor signal transduction and the control of hematopoietic cell development

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Rational design of potent antagonists to the human growth hormone receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

A sequential dimerization mechanism for erythropoietin receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Small peptides as potent mimetics of the protein hormone erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Saturation mutagenesis of the WSXWS motif of the erythropoietin receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Changes in conformation and stability upon formation of complexes of erythropoietin (EPO) and soluble EPO receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH-binding activity by abolishing receptor homodimerization

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Lyn tyrosine kinase is essential for erythropoietin-induced differentiation of J2E erythroid cells

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Phosphorylation of tyrosine 503 in the erythropoietin receptor (EpR) is essential for binding the P85 subunit of phosphatidylinositol (PI) 3-kinase and for EpR-associated PI 3-kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

A new protein containing an SH2 domain that inhibits JAK kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

A family of cytokine-inducible inhibitors of signalling

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Structure and function of a new STAT-induced STAT inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Oligomerization and scaffolding functions of the erythropoietin receptor cytoplasmic tail.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Signaling through the hematopoietic cytokine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Jak2 is essential for signaling through a variety of cytokine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Stat5a is mandatory for adult mammary gland development and lactogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2899%2900075-8

7 January 2021

10.1016/S1357-2725(99)00075-8

Identifiers

DOI

1 reference

release_usxtuwip2jagxa7c2vw2b7j2ri

29 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/usxtuwip2jagxa7c2vw2b7j2ri

24 November 2022

mapped directly with Wikidata item

PubMed ID

10582340

1 reference

PubMed ID

10582340